Explore more publications!
The Georgian Health Digest
Got News to Share?

The Georgian Health Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Georgian Health Digest.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on September 10, 2025

Trethera Successfully Completes Enrollment of Phase 1 Dose Escalation Trial for Patients with Solid Tumors
September 10, 2025

Trethera Successfully Completes Enrollment of Phase 1 Dose Escalation Trial for Patients with Solid Tumors

Indeterminate GlobeNewswire
Niederländische Plattform macht dermatologische Versorgung weltweit unmittelbar zugänglich
September 10, 2025

Niederländische Plattform macht dermatologische Versorgung weltweit unmittelbar zugänglich

Indeterminate GlobeNewswire
Une plateforme néerlandaise rend les soins dermatologiques instantanément accessibles dans le monde entier
September 10, 2025

Une plateforme néerlandaise rend les soins dermatologiques instantanément accessibles dans le monde entier

Indeterminate GlobeNewswire
Plataforma holandesa torna o atendimento dermatológico instantaneamente acessível em todo o mundo
September 10, 2025

Plataforma holandesa torna o atendimento dermatológico instantaneamente acessível em todo o mundo

Indeterminate GlobeNewswire
NanoNewron Awarded $2.5 Million in NIH STTR Phase 2 Grant to Advance its Innovative NN-840 Alzheimer’s Disease Program
September 10, 2025

NanoNewron Awarded $2.5 Million in NIH STTR Phase 2 Grant to Advance its Innovative NN-840 Alzheimer’s Disease Program

Indeterminate GlobeNewswire
KFSHRC Conducts 48% of Clinical Trials in Saudi Arabia During the First Half of 2025
September 10, 2025

KFSHRC Conducts 48% of Clinical Trials in Saudi Arabia During the First Half of 2025

Indeterminate GlobeNewswire
Saudi Food and Drug Authority, AAMI Partner on Medtech Best Practices
September 10, 2025

Saudi Food and Drug Authority, AAMI Partner on Medtech Best Practices

Indeterminate GlobeNewswire
neurocare group's Apollo TMS Therapy Devices Now Have FDA Clearance to Treat Adolescents Suffering With Major Depression
September 10, 2025

neurocare group's Apollo TMS Therapy Devices Now Have FDA Clearance to Treat Adolescents Suffering With Major Depression

Indeterminate GlobeNewswire
Eleos Launches Smarter Support for Group Therapy and SUD Care
September 10, 2025

Eleos Launches Smarter Support for Group Therapy and SUD Care

Indeterminate GlobeNewswire
NeOnc Technologies Receives FDA Authorization to Proceed with Phase II Clinical Trial of NEO212 – A First-in-Class Oral Chemical Conjugated Chemotherapy Candidate for Brain Cancer
September 10, 2025

NeOnc Technologies Receives FDA Authorization to Proceed with Phase II Clinical Trial of NEO212 – A First-in-Class Oral Chemical Conjugated Chemotherapy Candidate for Brain Cancer

Indeterminate GlobeNewswire
Wellcome Leap and Pivotal Commit $100 Million to Women’s Health Research to Deliver Breakthroughs in Years, Not Decades
September 10, 2025

Wellcome Leap and Pivotal Commit $100 Million to Women’s Health Research to Deliver Breakthroughs in Years, Not Decades

Indeterminate GlobeNewswire
Actuate Therapeutics Announces Pricing of $15.0 Million Public Offering of Common Stock
September 10, 2025

Actuate Therapeutics Announces Pricing of $15.0 Million Public Offering of Common Stock

Indeterminate GlobeNewswire
Artelo Biosciences Announces Publication of Preclinical Data Demonstrating Superior Efficacy and Bioavailability of ART12.11 in Reducing Stress-Induced Depression and Anxiety Symptoms
September 10, 2025

Artelo Biosciences Announces Publication of Preclinical Data Demonstrating Superior Efficacy and Bioavailability of ART12.11 in Reducing Stress-Induced Depression and Anxiety Symptoms

Indeterminate GlobeNewswire
Ernexa Therapeutics Provides Update on Operational Excellence and Performance
September 10, 2025

Ernexa Therapeutics Provides Update on Operational Excellence and Performance

Indeterminate GlobeNewswire
FibroBiologics Announces Significant Advancements in Bone Marrow Organoid Platform Enabling Development for Cancer and Immune-Related Therapies
September 10, 2025

FibroBiologics Announces Significant Advancements in Bone Marrow Organoid Platform Enabling Development for Cancer and Immune-Related Therapies

Indeterminate GlobeNewswire
JenaValve Announced ESC Guidelines Recognize TAVI as Class IIb Recommendation for Aortic Regurgitation
September 10, 2025

JenaValve Announced ESC Guidelines Recognize TAVI as Class IIb Recommendation for Aortic Regurgitation

Indeterminate GlobeNewswire
Catheter Precision Announces Tender Win and First Purchase Order in Croatia
September 10, 2025

Catheter Precision Announces Tender Win and First Purchase Order in Croatia

Indeterminate GlobeNewswire
Picard Announces Appointment of Two New Members to its Board of Directors
September 10, 2025

Picard Announces Appointment of Two New Members to its Board of Directors

Indeterminate GlobeNewswire
DeepView® System highlighted at the European Burns Association Congress
September 10, 2025

DeepView® System highlighted at the European Burns Association Congress

Indeterminate GlobeNewswire
National Fitness Partners and Penn State Athletics Continue the Fight Against Pediatric Cancer with 2025 “Sack for a Cure” Initiative
September 10, 2025

National Fitness Partners and Penn State Athletics Continue the Fight Against Pediatric Cancer with 2025 “Sack for a Cure” Initiative

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions